Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting changes and wording adjustments; there are no changes to core study details such as enrollment, eligibility criteria, primary outcomes, or treatment arms. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:14:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:09:00.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Terminology updated to a more specific form and version bumped to v3.1.0.
    Difference
    0.6%
    Check dated 2025-09-28T03:13:33.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; 'Back to Top' element removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:37:37.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T15:04:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include new resources related to head and neck cancer, along with a revision update to version 3.0.0, while removing several outdated terms and categories related to cancer treatment.
    Difference
    5%
    Check dated 2025-08-30T11:48:03.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.